Boult is pleased to announce that it has been ranked as “Outstanding” for non-contentious patent matters by the World Intellectual Property Review (WIPR) for 2026.
Boult is proud to be recognised in Lexology Index: IP 2026, with Dr Catherine Wolfe named a Global Elite Thought Leader and multiple partners ranked across the prestigious report.
Boult is pleased to announce that it has been ranked as “Outstanding” for non-contentious patent matters by the World Intellectual Property Review (WIPR) for 2026.
Boult is proud to be recognised in Lexology Index: IP 2026, with Dr Catherine Wolfe named a Global Elite Thought Leader and multiple partners ranked across the prestigious report.
The Advanced Materials Show brings together the full advanced materials supply chain, showcasing the latest developments in composites, polymers, ceramics,...
The Pharma & Biotech Patent Litigation Summit is a major European conference for life-sciences intellectual property professionals, focusing on patent...
LSPN Europe 2025 will focus on end-to-end patent lifecycle management, offering practical strategies for protecting and commercialising innovations in life...
BIO-Europe 2025 is Europe’s premier annual partnering conference for the biotechnology, pharmaceutical and investment sectors. With over 5,000 attendees from...
Organised by the Pharmaceutical Trademarks Group, this conference will bring together trademark professionals to discuss current challenges and opportunities in...
